Proteome Sciences (PRM)
PRM Share PerformanceMore
|52 week high||15.0180 24/08/16|
|52 week low||3.2500 16/08/17|
|52 week change||-10.9000 (-75.83%)|
|4 week volume||10,889,995 28/07/17|
Media for (PRM)
Latest News« previous» nextMore
01/08/2017 - 07:00 RNS
RNS Number: 6491M Proteome Sciences PLC 01 August 2017 1 August 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Directorate changes Proteome Sciences (AIM:PRM), is pleased to announce the appointment of Dr Ursula Ney as a Non-executive Director of the Company, with immediate effect, replacing Professor William Dawson who is stand...
25/07/2017 - 07:00 RNS
RNS Number: 9512L Proteome Sciences PLC 25 July 2017 25 July 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Interim results for the six months ended 30 June 2017 Proteome Sciences is pleased to announce its unaudited interim results for the six months ended 30 June 2017. Financial highlights: Total revenues increased 21% to 1.36m (2016: 1.12m)...
11/07/2017 - 13:25 StockMarketWire
Proteome Sciences has confirmed that the Company will announce its interim results for the six months ended 30 June on...
11/07/2017 - 12:00 RNS
RNS Number: 7216K Proteome Sciences PLC 11 July 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Notice of Results Proteome Sciences will announce its interim results for the six months ended 30 June 2017 on 25 July 2017. For further information: Proteome Sciences plc Dr Jeremy Haigh, Chief Executive Officer Tel: +44 (0)20 7043 2116 Dr Ian P...
30/06/2017 - 10:31 RNS
RNS Number: 7329J Proteome Sciences PLC 30 June 2017 TR-1:NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PROTEOME SCIENCES 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights NO An...
30/06/2017 - 07:50 StockMarketWire
Proteome Sciences said Randox Laboratories Ltd presented the first results from a prospective trial using its Rapid Stroke A...
30/06/2017 - 07:00 RNS
RNS Number: 6681J Proteome Sciences PLC 30 June 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Stroke Diagnostic Presentation at EuroMedLab 2017 - Research Milestone Achieved We are pleased to announce that Randox Laboratories Ltd, ("Randox") presented the first results from a prospective trial using its Rapid Stroke Array at the EuroM...
12/06/2017 - 07:00 RNS
RNS Number: 6479H Proteome Sciences PLC 12 June 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company" New Registered Address Proteome Sciences plc (AIM:PRM) is pleased to announce that its corporate headquarters have moved from Cobham to new premises in central London, and the Board has approved that from 12 June 2017 the new registere...
|Dividend yield||0 %|
Equity Research (PRM)
Proteome Sciences plc
Edison Investment Research is terminating coverage on Proteome Sciences (PRM). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now...
Proteome Sciences plc
Proteome Sciences signed its first major biomarker service contract in September. This followed on from the data from the 1,148-patient Alzheimer’s disease (AD) study, which could lead to a blood-...
Latest discussion posts More
“B'mango - hope you do well, and any glimps at the long term chart is a slutory experience (!) - one can only hope that PRM is at last on the turn (but waiting confirmation in ...”▼
“Half Year Results gave some remarkable insights: 1. TMT sales showed a nice increase. Unfortunately there seems to be a warning in the CEOs statement that the company runs ...”▼
“Being something of a chart fanatic, Andy, would you say a rise from here might confirm a bullish double bottom formation, or is the length of time between the two troughs too ...”▼
Codes & Symbols
|Symbols||PRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM|